C9orf72 and amyotrophic lateral sclerosis: In this context, our proteomics analysis of fibroblasts is the first one reporting a comparison between ALS patients carrying the C9ORF72 repeat expansion and ALS patients who tested negative for it, thus specifically investigating C9ORF72-related pathogenetic mechanisms in ALS.